Characteristics of human T-lymphotropic virus type-1 (HTLV-1)-infected cell line MT-2, which is not killed by a natural killer cell line NK-92 but is killed by lymphokine-activated killer cells

Oncology Research

Volumn 11, Issue 5, 1999, Pages 213-218

  Komatsu, Fumio ^a   Yoshida, Sayaka ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Human T lymphotropic virus type 1 (HTLV 1); Lymphokine activated killer (LAK); MT 2; Natural killer cell inhibitory receptor; NK 92

Indexed keywords

CHELATING AGENT; CITRIC ACID; HLA ANTIGEN CLASS 1; LEUKOCYTE ANTIGEN;

ARTICLE; CELL CULTURE; CELL DEATH; CELLULAR IMMUNITY; DRUG EFFECT; HISTOCOMPATIBILITY TEST; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOLOGY; LYMPHOKINE ACTIVATED KILLER CELL; METABOLISM; METHODOLOGY; NATURAL KILLER CELL; VIROLOGY;

ANTIGENS, CD; CELL DEATH; CHELATING AGENTS; CITRIC ACID; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; TUMOR CELLS, CULTURED;

EID: 0033254887     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Osborn, L.; Day, E. S.; Miller, G. T.; Karpusas, M.; Tizard, R.; Meuer, S. C.; Hochman, P. S. Amino acid residues required for binding of lymphocyte function-associated antigen 3 (CD58) to its counter-receptor CD2. J. Exp. Med. 181:429-434; 1995.
2. Gwin, J. L.; Gercel-Taylor, C.; Taylor, D. D.; Eisenberg, R. Role of LFA-3, ICAM-1, and MHC class I on the sensitivity of human tumor cells to LAK cells. J. Surg. Res. 60:129-136; 1996.
3. Vitale, M.; Sivori, S.; Pende, D.; Moretta, L.; Moretta, A. Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells. Proc. Natl. Acad. Sci. USA 92: 3536-3540; 1995.
4. Gumperz, J. E.; Valiante, N. M.; Parham, P.; Lanier, L. L.; Tyan, D. Heterogenous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibility complex haplotype. J. Exp. Med. 183:1817-1827; 1996.
5. Dohring, C.; Scheidegger, D.; Samaridis, J.; Cella, M.; Colonna, M. A human killer inhibitory receptor specific for HLA-A. J. Immunol. 156:3098-3101; 1996.
6. Braud, V. M.; Allan, D. S. J.; O'Callaghan, C. A.; Soderstrom, K.; D'Andrea, A.; Ogg, G. S.; Lazetic, S.; Young, N. T.; Bell, J. I.; Phillips, J H.; Lanier, L. L.; McMichael, A. J. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391: 795-799; 1998.
7. Gong, J-H.; Maki, G.; Klingeman, H-G. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 8:652-658; 1994.
8. Goodman, D. J.; von Albertini, M. A.; McShea, A.; Wrighton C. J.; Bach, F. H. Adenoviral-mediated overexpression of Iκ Bα in endothelial cells inhibits natural killer cell-mediated endothelial cell activation. Transplantation 62:967-972; 1996.
9. Klingemann, H-G.; Wong, E.; Maki, G. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood. Biol. Blood Marrow Transpl. 2:68-75; 1996.
10. Klingemann, H-G.; Miyagawa, B. Purging of malignant cells from blood after short ex vivo incubation with NK-92 cells. Blood 87: 4913-4914; 1996.
11. Komatsu, F.; Kajiwara, M. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells. Oncol. Res. 10:483-489; 1998.
12. Miyoshi, I.; Kubonishi, I.; Yoshimoto, S.; Shiraishi, Y. A T-cell line derived from normal human cord leukocytes by co-culturing with human leukemic T-cells. Gann (Jpn. J. Cancer Res.) 72:978-981; 1981.
13. Bensussan, A.; Mansur, I.; Mallet, V.; Rodriguez, A. M.; Girr, M.; Weiss, E. H.; Brem, G.; Boumsell, L.; Gluckman, E.; Dausset, J.; Carosella, E.; Le Bouteiller, P. Detection of membrane-bound HLA-G translated products with a specific monoclonal antibody. Proc. Natl. Acad. Sci. USA 92:10292-10296; 1995.
14. Pazmany, L.; Mandelboim, O.; Vales-Gomez, M.; Davis, D. M.; Reyburn, H. T.; Strominger, J. L. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 274:792-795; 1996.
15. Sonoda, S.; Yashiki, S.; Takahashi, K.; Arima, N.; Daitoku, Y.; Matsumoto, M.; Matsumoto, T.; Tara, M.; Shinmyozu, K.; Sato, K.; Inoko, H. Altered HLA antigens expressed on T and B lymphocytes of adult T-cell leukemia/lymphoma patients and their relatives. Int. J. Cancer 40:629-634; 1987.
16. Uno, H.; Matsuoka, H.; Suzuki, M.; Tsuda, K.; Tsubouchi, H. Altered expression of class I HLA antigen on peripheral mononuclear cells in patients with adult T-cell leukemia: Inverse relationship with natural killer susceptibility. Cancer Epidemiol. Biomarkers Prev. 4:367-372; 1995.
17. Plotnicky, H.; Cyblat, D.; Vernant, J-C.; Desgranges, C. IL-2-dependent HTLV-1-infected T cells escape from non-specific, MHC-unrestricted cellular cytotoxicity. Clin. Immunol. Immunopathol. 73:205-214; 1994.
18. Farrell, H. E.; Vally, H.; Lynch, D. M.; Fleming, P.; Shellam, G. R.; Scalzo, A. A.; Davis-Poynter, N. J. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 386:510-514; 1998.
19. Reybum, H. T.; Mandelboim, O.; Vales-Gomez, M.; Davis, D. M.; Pazmany, L.; Strominger, J. L. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386:514-517; 1997.